Allergen Immunotherapy in Allergic Patients
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Inclusion Criteria
- allergic rhinitis/asthma
- allergic rhinitis/asthma
Exclusion Criteria
- pregnancy,
- autoimmunity
- malignity,
- pregnancy,
- autoimmunity
- malignity,
Summary
- Conditions
- Allergic Rhinitis
- Design
- Observational Model: Case-Control
- Time Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Allergic rhinitis patients sensitized to at least one common aero-allergen who completed a three or five year period of allergen immunotherapy in our outpatient clinic between 2002-2013 were enrolled in the study and patients with allergic rhinitis who received only medical treatment were chosen as ...
Allergic rhinitis patients sensitized to at least one common aero-allergen who completed a three or five year period of allergen immunotherapy in our outpatient clinic between 2002-2013 were enrolled in the study and patients with allergic rhinitis who received only medical treatment were chosen as the control group. Patients were separated in two groups according to sensitization patterns including pollens or house dust mites. All patients were evaluated before immunotherapy, in the first and the fifth years of treatment and two years after the treatment.
Inclusion Criteria
- allergic rhinitis/asthma
- allergic rhinitis/asthma
Exclusion Criteria
- pregnancy,
- autoimmunity
- malignity,
- pregnancy,
- autoimmunity
- malignity,
Tracking Information
- NCT #
- NCT02040974
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mustafa Demirturk Istanbul Faculty of Medicine
- Mustafa Demirturk Istanbul Faculty of Medicine
Get Well Soon